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OBJECTIVE: To evaluate the effects of the levels of glycemic control on the frequency of clinical complications
following invasive dental treatments in type 2 diabetic patients and suggest appropriate levels of fasting blood
glucose and glycated hemoglobin considered to be safe to avoid these complications.
METHOD: Type 2 diabetic patients and non-diabetic patients were selected and divided into three groups. Group I
consisted of 13 type 2 diabetic patients with adequate glycemic control (fasting blood glucose levels,140 mg/dl
and glycated hemoglobin (HbA1c) levels,7%). Group II consisted of 15 type 2 diabetic patients with inadequate
glycemic control (fasting blood glucose levels.140 mg/dl and HbA1c levels .7%). Group III consisted of 18 non-
diabetic patients (no symptoms and fasting blood glucose levels,100 mg/dl). The levels of fasting blood glucose,
glycated HbA1c, and fingerstick capillary glycemia were evaluated in diabetic patients prior to performing dental
procedures. Seven days after the dental procedure, the frequency of clinical complications (surgery site infections
and systemic infections) was examined and compared between the three study groups. In addition, correlations
between the occurrence of these outcomes and the glycemic control of diabetes mellitus were evaluated.
RESULTS: The frequency of clinical outcomes was low (4/43; 8.6%), and no significant differences between the
outcome frequencies of the various study groups were observed (p.0.05). However, a significant association was
observed between clinical complications and dental extractions (p=0.02).
CONCLUSIONS: Because of the low frequency of clinical outcomes, it was not possible to determine whether
fasting blood glucose or glycated HbA1c levels are important for these clinical outcomes.
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& INTRODUCTION
Diabetes mellitus (DM) is a progressive chronic disease that
has a high level of morbidity because of the comorbidities that
occur during disease evolution, which can compromise patient
quality of life (1). One of the most important complications of
DM is the observed increase in susceptibility to infections (2),
likely due to impaired immunological defenses (3), which
have been associated with increased concentrations of plasma
glucose (4). It has been reported that chronic hyperglycemia
accelerates the accumulation of advanced glycated end-
products (AGEs) (5), which results in local tissue alterations
that can increase susceptibility to infections (6).
It is important to be able to identify patients who have an
elevated risk of developing oral complications related to
invasive dental procedures. Thus, this study aimed to evaluate
the frequency of clinical complications following invasive
dental procedures in type 2 diabetic patients based on their
levels of glycemic control. Furthermore, this study sought to
determine the levels of fasting blood glucose (FBG) andHbA1c
that could be considered safe to avoid these complications.
& SUBJECTS AND METHODS
Ethics statement
This study was approved by the Ethics Committee of the
Dentistry School of Ribeira˜o Preto, Sa˜o Paulo University,
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Brazil (CAAE #0012.0.138.000-10). All subjects provided
written informed consent prior to their participation in this
study.
Subjects
Type 2 diabetic patients and non-diabetic patients over 35
years of age were selected and divided into three groups.
The study cohort consisted of individuals of both genders
and a range of ethnicities. Group I consisted of type 2
diabetic patients with adequate glycemic control (FBG levels
below 140 mg/dl and HbA1c levels less than 7%). Group II
consisted of type 2 diabetic patients with inadequate
glycemic control (FBG levels .140 mg/dl and HbA1c levels
.7%). Group III was the control group and consisted of
non-diabetic patients (no symptoms of diabetes and FBG
levels ,100 mg/dl). Diabetes diagnoses were made based
on the World Health Organization (WHO) recommenda-
tions (7). All diabetic patients included in this study had met
the diagnostic criteria for diabetes for at least five years. The
following inclusion criteria were used: at least six teeth, a
requirement for dental surgery (simple extraction) or
complex periodontal treatment (non-surgical scaling and
root planning). The need for extraction was evaluated using
clinical and radiographic examinations. The requirement for
periodontal treatment was evaluated via periodontal screen-
ing and recording (PSR), and patients classified as PSR 3 or
4 codes were selected. Subjects were excluded if they
presented with co-existing local or systemic infections,
severe complications related to diabetes, or if they had
received antimicrobial treatment for oral infections in the
previous three months.
Study design
A case-control study was developed and performed
between May 2010 and November 2011. The charts from
diabetic patients treated at the Diabetes Outpatient Clinics
of the University Hospital of the Medical School of Ribeira˜o
Preto, Sa˜o Paulo University, were reviewed, and patients
that met the eligibility criteria were referred to the Dental
School of Ribeira˜o Preto for dental treatments. Patients for
the control group were selected from the clinics of the
Dental School of Ribeira˜o Preto. Prior to performing any
dental work, the levels of FBG, HbA1c, and fingerstick
capillary glycemia (FCG) were determined in all type 2
diabetic patients. Seven days after the dental procedure, the
frequency of clinical complications (surgery site infections
and systemic infections) in the three study groups was
analyzed. In addition, the presence of tissue necrosis,
purulent secretion, pain, edema, and dehiscence/wound
breakdown was examined. Symptoms were registered using
a 10-cm visual analog scale (VAS; 0 =no pain to 10 = extreme
pain). The correlations between clinical outcomes and
dental procedures, clinical outcomes and symptoms,
and symptoms and type of dental procedure were also
evaluated.
Statistical analysis
Fisher’s exact tests were used to evaluate the differences
in clinical outcomes after invasive dental procedures in the
three groups, the association between clinical outcome and
procedure type, and the effects of gender in each of the three
groups. These analyses were performed using SAS software
(Statistical Analysis System - SASH 9.0 software; Cary, NC,
USA). Differences in age, glycemic control, and symptoms
reported by the patients between the three groups were
analyzed using Kruskal-Wallis tests with Dunn post hoc
tests, and these analyses were performed using R software
(R Foundation for Statistical Computing, Vienna, Austria;
http://www.r-project.org). The data were reported as the
means and standard deviation (SD), and the level of
significance was set at 5% for all analyses.
& RESULTS
The demographic characteristics and glycemic control of
the subjects are shown in Table 1. After reviewing 1,175
charts for inclusion and exclusion criteria, 147 type 2
diabetics were initially selected. However, only 28 subjects
were found to be eligible for the current study. Of these, 13
subjects had type 2 diabetes with adequate glycemic control
(Group I), and 15 exhibited inadequate glycemic control
(Group II). The other 119 patients were excluded for at least
Table 1 - Clinical characteristics of type 2 diabetic patients with adequate (Group I) and inadequate glycemic control
(Group II) and non-diabetic subjects (Group III) and the frequency of symptom levels (0-5 and 6-10) reported after dental
invasive procedures.
Variables Group I (n = 13) Group II (n = 15) Group III (n = 18) p-value
Gender*
Male 7 (53.8%) 4 (26.7%) 3 (16.6%) 0.10{
Female 6 (46.2%) 11 (73.3%) 15 (83.4%)
Age (years)
Mean ¡ SD 58.53¡6.11 52.86¡7.24 46.53¡7.61 ,0.01{
Capillary glycemia (mg/dl)**
Mean ¡ SD 151.33¡39.80 240.93¡72.89 105.26¡22.91 ,0.01{
Fasting blood glucose (mg/dL)**
Mean ¡ SD 134.76¡25.18 197.33¡71.79 88.73¡9.78 ,0.01{
HbA1c (%)**
Mean ¡ SD 6.5¡0.50 10.22¡1.33 - ,0.01{
Clinical outcomes*
No 12 (92.3%) 13 (86.6%) 17 (94.4%) 0.81{
Yes 1 (7.7%) 2 (13.3%) 1 (5.6%)
Symptoms (VAS)
0-5 12 (92.3%) 14 (93.4%) 17 (94.4%) 0.80{
6-10 1 (7.7%) 1 (6.6%) 1 (5.6%)
*Values shown as n (%); ** values shown as the means and standard deviation (SD); { Fisher’s exact test; { Kruskal-Wallis test; VAS: visual analog scale.
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one of the following reasons: FBG levels .300 mg/dl and/
or HbA1c levels .10%, which are associated with complica-
tions of diabetes; not having at least six teeth; or refusing to
participate in the study. Eighteen non-diabetic patients were
also studied as a control group (Group III). FBG, HbA1c,
and FCG levels were higher in type 2 diabetic patients with
inadequate glycemic control compared with those with
adequate glycemic control.
The frequency of clinical complications was low and
similar (p= 0.80) in the three groups, and this frequency was
independent of glycemic control (Table 1). Of the 46 patients
examined here, only four (8.6%) showed oral complications:
one in Group I, two in Group II, and one in Group III. These
four patients were treated by dental extraction, and their
outcomes were all characterized by intra-oral swelling,
redness, pus, and wound dehiscence. All 27 patients
underwent scaling and root planning, which did not induce
any complications. Thus, dental extractions were associated
with increased numbers of complications compared with
scaling and root planning (p=0.02) (Table 2).
Most patients (43/46; 93.4%) reported pain symptoms
ranging from 0 and 5 (VAS), but three patients reported
symptoms ranging from 6 to 10 (Table 1). All of the patients
who received scaling and root planning had VAS scores of 5
or lower, and all three of the patients who reported
symptoms greater than 6 had undergone extractions (of 19
total, 15.7%) (Table 2). However, no significant associations
were observed between the clinical outcomes and symp-
toms (p= 0.81) or between the type of dental procedure and
symptoms (p=0.20).
& DISCUSSION
This study evaluated the frequency of postoperative
dental complications in patients with type 2 diabetes based
on their levels of glycemic control. The results demonstrated
a low frequency of complications, and no evidence of an
effect of glycemic control on clinical outcomes was observed
(Table 1). Of the 46 patients who underwent invasive
procedures, only four (8.6%) had surgical site infections,
and this outcome occurred in patients from each of the three
groups: one patient from Group I, two patients from Group
II and one patient from Group III.
The following FBG and FCG values were observed in the
patients who had postoperative complications: FBG=
137 mg/dl and FCG=225 mg/dl (Group I patient);
FBG=219 mg/dl; FCG=300 mg/dl and FBG=301 mg/dl;
FCG=195 mg/dl (Group II patients); and FBG=88 mg/dl;
FCG=98 mg/dl (Group III patient). Regarding the HbA1c
values, the three diabetic patients who had postoperative
complications had HbA1c values as follows: 7% (Group I
patient) and 9% and 11% (Group II patients).
The use of antibiotics has been recommended for type 2
diabetics prior to dentoalveolar surgery (8,9) to prevent
surgical site infections and facilitate the healing process. In
this study, antibiotics were not used prior to dental
procedures in any of the groups, but the frequency of
clinical complications was low nonetheless. The similar
prevalence of surgical site infections in type 2 diabetic
patients with adequate and inadequate glycemic control and
in non-diabetics suggests that the rate of infections may not
depend on glycemic control, despite the reports of an
increased risk of infections in diabetic patients (10). In
addition, these results suggest that antibiotic prophylaxis
may only be appropriate in specific cases, not during
routine practice. All of the patients in the current study were
treated with local antibiotic irrigation, and the surgical
wounds of all patients were clinically repaired within 10
days.
The present study failed to identify a direct relationship
between FBG levels or HbA1c values and postoperative
complications; thus, it was impossible to suggest FBG or
HbA1c values that would be predictive of complications.
This study did reveal that dental extractions are more
frequently characterized by complications than scaling and
root planning procedures, but this effect was not linked to
glycemic control. The limitations of this study included the
small number of patients and the fact that postoperative
FBG values were not evaluated. It is possible that studies
with larger sample sizes might be sufficiently powered to
assess the impact of glycemic control on the occurrence of
postoperative complications.
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